ANNIE ZAVITSANOS: Open Payments
NPI 1508398819 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 40 payments from 22 companies in 2025. Trend: 2023 $85 · 2024 $83 · 2025 $1,042
Food & beverage: $943Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $141 |
| Janssen Biotech, Inc. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| Astellas Pharma US Inc | 3 | $83 |
| Genmab U.S., Inc. | 3 | $78 |
| Galderma Laboratories, L.P. | 3 | $65 |
| GENZYME CORPORATION | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Lilly USA, LLC | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
Products named: KISQALI, XTANDI, ERLEADA, Epkinly, KEYTRUDA, VERZENIO, LIBTAYO, TALVEY.
Industry payments across PA — which companies pay providers there.
